Annex DTR3 Notification of Transactions of

New Post Public Reply Private Reply Replies (0) Message Board
testuser
 Annex DTR3 Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons  All relevant boxes should be completed in block capital letters. 1.Name of the issuer 2.State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).  REXAM PLC (i)3.Name of person discharging managerialresponsibilities/director  4.State whether notification relates to a personconnected with a person discharging managerial responsibilities/director named in 3 and identify the connected person  CARLOS MEDEIROS  -5.Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficialinterest 1 6.Description of shares (including class), debentures or derivatives or financial instruments relating to shares  PDMR ORDINARY SHARES OF 64 2/7 PENCE EACH7.Name of registered shareholders(s) and, if more than one, the number of shares held by each of them 8.State the nature of the transaction   - GRANT OF 2012 AWARD UNDER REXAM LONG TERM INCENTIVE PLAN 20099.Number of shares, debentures or financialinstruments relating to shares acquired 10.Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)  - -11.Number of shares, debentures or financialinstruments relating to shares disposed 12.Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)  - -13.Price per share or value of transaction 14.Date and place of transaction  - -15.Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage) 16.Date issuer informed of transaction     - - If a person discharging managerial responsibilities has been granted options by the issuercomplete the following boxes 17.Date of grant  18.Period during which or date on which exercisable  21 NOVEMBER 2012 SUBJECT TO VESTING 21 NOVEMBER 201519.Total amount paid (if any) for grant of the option20.Description of shares or debentures involved (class and number)  - ORDINARY SHARES OF 64 2/7 PENCE EACH; 115,70421.Exercise price (if fixed at time of grant) orindication that price is to be fixed at the time of exercise 22.Total number of shares or debentures over which options held following notification  - -23.Any additional information 24.Name of contact and telephone number for queries  PERFORMANCE CONDITIONS APPLY OVER THREE YEAR MEASUREMENT PERIOD JENNIFER SMITH 020 7227 4132  Name of authorised official of issuer responsible for making notification JENNIFER SMITH Date of notification 22 NOVEMBER 2012    Notes:    This form is intended for use by an issuer to make a RIS notification required by DR 3.3. (1)An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.(2)An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.(3)An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.(4)An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. 
Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 354

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 627

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 26

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 129

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 27

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
ASMAX Unleashes Next-Level Motorcycle Comms at EICMA

Updated Category News Views 50

Transforming the Motorcycle Communication Landscape Motorcycling ain't just about the roaring engines and the rubber on the road. In the world of helmets and handlebars, some bright minds are weaving tech magic at the EICMA 2026 in Milan. ASMAX has rolled out its shiny new RoamX intercom gadget, leaving folks buzzing at Hall 6. What RoamX Brings to the Table This ain't...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

Iceland Seafood International hf Announces Successful Bill Auction

Updated Category News Views 171

Iceland Seafood International hf's Successful Auction Iceland Seafood International hf. has recently completed an offering of 3-month bills under the new series ICESEA 25 0304. This significant milestone reflects the company's ongoing efforts to strengthen its financial position and enhance its market presence. Details of the Bill Auction The total offers for the bills...

Continue Reading
Prolong Pharmaceuticals Showcases PP-007 in Innovative Stroke Study

Updated Category News Views 194

Prolong Pharmaceuticals Highlights Phase 1 Results for Acute Ischemic Stroke Treatment Prolong Pharmaceuticals, LLC, a clinical-stage biopharmaceutical firm, is making waves in the medical community with its recent announcement regarding the preliminary data from the HEMERA-1 trial. This significant study looks into the effects of their lead asset, PP-007, in treating...

Continue Reading
Investors Urged to Join Class Action Against Verve Therapeutics

Updated Category News Views 89

Investors: Consider Joining the Verve Therapeutics Class Action Robbins LLP, a shareholder-rights law firm, is reminding investors about an important window to act in the class action against Verve Therapeutics, Inc. (NASDAQ: VERV). The lawsuit covers individuals and entities that bought or otherwise acquired Verve securities during a defined time frame. Verve is a...

Continue Reading
Top Dividend Stocks for Passive Income Success

Updated Category News Views 246

Building Passive Income Through Smart Investments Creating passive income is a crucial element of a successful early retirement plan. Establishing various sources of passive income is important to reduce the pressure of depending solely on active work for financial support. A key aspect of this strategy is investing in companies known for their above-average dividends,...

Continue Reading
Temperature Monitoring Devices Market Expected to Surge

Updated Category News Views 61

The temperature monitoring devices market experienced a notable surge back in 2024, with projections estimating a compound annual growth rate (CAGR) of 4.5% through to 2034. By the end of that forecast period, sales revenue was set to hit around USD 5.3 billion—a clear indicator of robust expansion in this critical sector. Market Dynamics: Diverse Applications Across...

Continue Reading